StockData
Thermo Fisher Scientific Inc. logo

Thermo Fisher Scientific Inc. (TMO) stock

TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 10/3028% above fair value
$686.79−4.54 (-0.66%)

Close on Nov 17, 2026Market cap $254.47BP/E 36.2Yield 0.25%

Thermo Fisher Scientific operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Thermo Fisher Scientific's operating income for the twelve months ending Sep 26, 2026 was $8.47B, up 12.8% year over year. For fiscal 2025 it was $7.75B, up 5.6% from the year before. Over ten years it grew 12.7% a year on average. The highest annual figure on record is $10.03B in fiscal 2021.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$7.75B+5.6%
FY2024Dec 31, 2024$7.34B+7.0%
FY2023Dec 31, 2023$6.86B-18.3%
FY2022Dec 31, 2022$8.39B-16.3%
FY2021Dec 31, 2021$10.03B+28.7%
FY2020Dec 31, 2020$7.79B+69.7%
FY2019Dec 31, 2019$4.59B+21.4%
FY2018Dec 31, 2018$3.78B+27.8%
FY2017Dec 31, 2017$2.96B+20.4%
FY2016Dec 31, 2016$2.46B+5.2%
FY2015Dec 31, 2015$2.34B-6.7%
FY2014Dec 31, 2014$2.50B+55.5%
FY2013Dec 31, 2013$1.61B+8.6%
FY2012Dec 31, 2012$1.48B+18.5%
FY2011Dec 31, 2011$1.25B+5.3%
FY2010Dec 31, 2010$1.19B+18.6%
FY2009Dec 31, 2009$1.00B-18.5%
FY2008Dec 31, 2008$1.23B+26.2%
FY2007Dec 31, 2007$974.40M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 26, 2026$2.26B+16.6%
Q2 FY2026Jun 27, 2026$2.09B+13.8%
Q1 FY2026Mar 28, 2026$1.86B+8.6%
Q4 FY2025Dec 31, 2025$2.26B+11.9%
Q3 FY2025Sep 27, 2025$1.94B+5.6%
Q2 FY2025Jun 28, 2025$1.83B+0.8%
Q1 FY2025Mar 29, 2025$1.72B+3.2%
Q4 FY2024Dec 31, 2024$2.02B+8.7%
Q3 FY2024Sep 28, 2024$1.84B-1.4%
Q2 FY2024Jun 29, 2024$1.82B+15.3%
Q1 FY2024Mar 30, 2024$1.66B+6.4%
Q4 FY2023Dec 31, 2023$1.85B-0.4%
Q3 FY2023Sep 30, 2023$1.86B+9.0%
Q2 FY2023Jul 1, 2023$1.58B-21.1%
Q1 FY2023Apr 1, 2023$1.56B-44.6%
Q4 FY2022Dec 31, 2022$1.86B-26.7%
Q3 FY2022Oct 1, 2022$1.71B-24.9%
Q2 FY2022Jul 2, 2022$2.00B-7.5%
Q1 FY2022Apr 2, 2022$2.82B-7.5%
Q4 FY2021Dec 31, 2021$2.54B-17.4%
Q3 FY2021Oct 2, 2021$2.28B-6.1%
Q2 FY2021Jul 3, 2021$2.16B+55.5%
Q1 FY2021Apr 3, 2021$3.05B+236.5%
Q4 FY2020Dec 31, 2020$3.07B+149.3%
Q3 FY2020Sep 26, 2020$2.43B+156.4%
Q2 FY2020Jun 27, 2020$1.39B-7.0%
Q1 FY2020Mar 28, 2020$906.00M-1.5%
Q4 FY2019Dec 31, 2019$1.23B+7.3%
Q3 FY2019Sep 28, 2019$946.00M+3.7%
Q2 FY2019Jun 29, 2019$1.50B+59.7%
Q1 FY2019Mar 30, 2019$920.00M+17.0%
Q4 FY2018Dec 31, 2018$1.15B+20.0%
Q3 FY2018Sep 29, 2018$912.00M+43.8%
Q2 FY2018Jun 30, 2018$937.00M+25.1%
Q1 FY2018Mar 31, 2018$786.00M+26.8%
Q4 FY2017Dec 31, 2017$957.00M+25.7%
Q3 FY2017Sep 30, 2017$634.00M–
Q2 FY2017Jul 1, 2017$749.00M–
Q1 FY2017Apr 1, 2017$620.00M–
Q4 FY2016Dec 31, 2016$761.40M–

More Thermo Fisher Scientific figures

See a number that looks wrong?